UNSPSC 51386003: Bufezolac

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C21H22N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PUA774J9MP, chemically known as 1-isobutyl-3,4-diphenylpyrazole-5-acetic acid but generally known as bufezolac, which bears US NIH Compound Identifier 68676. European Medicines Agency schedules Bufezolac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05962MIG.

UNSPSC 51386003 Bufezolac is a Commodity code that encompasses pharmaceutical products and drug-related supplies procured by state and local health agencies. The recent solicitation activity under this code reflects purchasing of naloxone and drug deactivation systems rather than bufezolac specifically, indicating that state and local procurement systems tag related pharmaceutical and public-health products under this classification. Issuing bodies using this code include county health departments and community health agencies managing opioid-response and substance-abuse prevention initiatives. The scope of work spans acquisition of pharmaceutical supplies and harm-reduction equipment in quantities and delivery schedules tied to public health program operations.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building at 520 W. Lake Mary Blvd, Sanford, FL 32771. The bid response deadline was July 26, 2023 at 2:00 pm. The contract carries a two-year initial term with one-year renewal option; vendors must include all shipping and delivery costs in proposals, provide E-Verify compliance certification, and maintain workers' compensation, commercial general liability, and professional liability insurance. The procurement included a three-month probationary period permitting termination with or without cause. No explicit set-aside designations were specified, though FEMA funding potentially introduced additional federal compliance requirements including adherence to the Clean Air Act and Federal Water Pollution Control Act.